Madrigal Pharmaceuticals (MDGL) Q1 2026 Earnings

19FebConfirmed
Q2 2025
Q3 2025
Q4 2025
Next
-5.08
-3.69
-2.29
-0.9

Details

Expected EPS
-0.895174
Actual EPS
N/A
Surprise EPS
0.9
Surprise Percent
+100%

Description

Madrigal Pharmaceuticals (MDGL) will report earnings of for Q1 2026 on February 19, 2026.

0 Comments

Share your thoughts